Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001569226-25-000005
Filing Date
2025-10-28
Accepted
2025-10-28 18:30:21
Documents
1
Period of Report
2025-10-28

Document Format Files

Seq Description Document Type Size
1 form4-10282025_061017.html 4  
1 form4-10282025_061017.xml 4 11358
  Complete submission text file 0001569226-25-000005.txt   12933
Mailing Address C/O MYOS CORPORATION 45 HORSEHILL ROAD, SUITE 106 CEDAR KNOLLS NJ 07927
Business Address
Srivastava Sapna (Reporting) CIK: 0001569226 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40384 | Film No.: 251426192

Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Issuer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)